Alzheimer's disease (AD) is the leading cause of dementia, with the number of patients with AD expected to double in the next quarter-century. Brain deposition of amyloid-β (Aβ) and tau proteins is a necessary but insufficient condition for AD ...
Chihara, Norio +6 more
core
Correction: Quansah et al. The Beneficial Effects of Lactobacillus Strains on Gut Microbiome in Alzheimer's Disease: A Systematic Review. <i>Healthcare</i> 2025, <i>13</i>, 74. [PDF]
Quansah M +7 more
europepmc +1 more source
Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional Study. [PDF]
Kupjetz M +19 more
europepmc +1 more source
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis. [PDF]
Costa-Frossard L +22 more
europepmc +1 more source
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis. [PDF]
Fissolo N +26 more
europepmc +1 more source
Reports of the Clinician's Demise Are Greatly Exaggerated: Clinical Judgment Remains Key in Diagnosing MOGAD. [PDF]
Buciuc M, Flanagan EP.
europepmc +1 more source
Glial cells: managers of Neuro-immunityEditorial
Carlos eBarcia +3 more
doaj +1 more source
Global trends in research of neuroimmune in lung diseases over past decade: a bibliometric analysis. [PDF]
Zhao Y, Li C, Cheng Y, Dai W.
europepmc +1 more source
Editorial: Exploring gut neuroimmunology: focus on the enteric nervous system in health and disease. [PDF]
Otero-Losada M, Bhave S, Dora D.
europepmc +1 more source

